Refractory epilepsy and medical cannabis
According to data from the World Health Organisation (WHO) epilepsy affects about 50 million people worldwide. In fact, it is one of the most common chronic neurological disorders.
This disease is characterized by recurrent seizures, ie short episodes of involuntary movements affecting a particular part of the body, or its entirety. Occasionally, during the episode of seizures, whether partial or generalized, people with epilepsy may also lose consciousness and control of the sphincters.
Refractory epilepsy is when epileptic seizures are so frequent that they prevent the person from leading a normal life. In many cases, it is because the prescribed anti-epileptic drugs (AEDs) are not having the desired results to diminish or to stop these problems. Refractory epilepsy continues to be an increasing clinical problem and accounts for 35% of patients experiencing seizures, and mainly affects children and adolescents.
- Reduction of seizures
- Can occur in children and adolescents
- Progressive studies with AED resistant patients
- Improvement in alertness
- Improvement in motor skills
Different trials have shown the anti-convulsive effects of cannabinoids for people with refractory epilepsy, which have considerably reduced seizure patterns and have improved overall alertness and motor function.
The use of cannabis for the treatment of refractory epilepsy
Research has shown the benefits of cannabinoids in epilepsy treatments for patients. In the case of refractory epilepsy, a study was conducted in 2015 about the use of oral cannabis extracts for pediatric patients with epilepsy, the study concluded that some of the families had reported that improvements had occurred.
In the United States, the results of a study partaken by 213 people with epilepsy who did not respond to antiepileptic treatments were presented in April 2015. They all received a cannabinoid based product (99% compounded by cannabidiol) to see what type of results were obtained with this new type of treatment. They found that among the 137 patients who followed the treatment for 12 weeks, seizures were reduced by an average of 54% .
At Kalapa Clinic we are currently conducting a study on refractory epilepsy and cannabinoids. If you are interested in obtaining more information or being part of our study, you can contact us.
Bibliography for Refractory Epilepsy and Cannabinoids
 Press, CA. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav. 2015 Apr;45:49-52.
Use cannabinoids for